Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-28

FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

The FDA approved a supplemental application for AUBAGIO (teriflunomide) submitted by Genzyme Corporation. This action updates the approved labeling/indication f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUBAGIO (TERIFLUNOMIDE)

Snippet

SUPPL AP for AUBAGIO (TERIFLUNOMIDE)